Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$435M |
| 2 |
Amazon
AMZN
|
+$334M |
| 3 |
Moderna
MRNA
|
+$53.9M |
| 4 |
Linde
LIN
|
+$44.2M |
| 5 |
DTE Energy
DTE
|
+$43.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$63.6M |
| 2 |
Comcast
CMCSA
|
+$39.7M |
| 3 |
Evergy
EVRG
|
+$38.5M |
| 4 |
Public Service Enterprise Group
PEG
|
+$38.4M |
| 5 |
Bio-Techne
TECH
|
+$30.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.37% |
| 2 | Consumer Discretionary | 10.36% |
| 3 | Financials | 7.14% |
| 4 | Industrials | 6.8% |
| 5 | Healthcare | 6.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Yext
YEXT
$660M
| $1.35M | 0.01% |
+94,303
| New | +$1.31M |
|
852
La-Z-Boy
LZB
$1.28B
| $1.35M | 0.01% |
36,345
+30,496
| +521% | +$1.28M |
|
|
AGNT
853
AGNT Inc
AGNT
$762M
| $1.34M | 0.01% |
+34,597
| New | +$1.19M |
|
854
Goodyear
GT
$1.78B
| $1.33M | 0.01% |
+77,827
| New | +$1.43M |
|
855
Invitation Homes
INVH
$17.9B
| $1.32M | 0.01% |
+35,505
| New | +$1.26M |
|
856
BWX Technologies
BWXT
$13.7B
| $1.32M | 0.01% |
+22,768
| New | +$1.46M |
|
857
Theravance Biopharma
TBPH
$884M
| $1.32M | 0.01% |
+90,864
| New | +$1.71M |
|
858
Dick's Sporting Goods
DKS
$11.1B
| $1.32M | 0.01% |
+13,138
| New | +$1.18M |
|
859
iQIYI
IQ
$994M
| $1.31M | 0.01% |
84,378
-262,096
| -76% | -$3.9M |
|
860
Kennametal
KMT
$2.23B
| $1.31M | 0.01% |
+36,542
| New | +$1.43M |
|
|
AUD
861
CALL
DELISTED
Audacy, Inc.
AUD
| $1.31M | 0.01% |
300,000
+50,000
| +20% | +$230K |
|
|
GLDD
862
DELISTED
Great Lakes Dredge & Dock
GLDD
| $1.31M | 0.01% |
89,409
-51,573
| -37% | -$762K |
|
|
CGC
863
Canopy Growth
CGC
$481M
| $1.3M | 0.01% |
5,392
+286
| +6% | +$73.2K |
|
|
OPLN
864
Openlane
OPLN
$4.19B
| $1.3M | 0.01% |
+74,085
| New | +$1.26M |
|
865
Hanover Insurance
THG
$7.91B
| $1.3M | 0.01% |
9,583
+1,674
| +21% | +$230K |
|
|
AL
866
DELISTED
Air Lease Corp
AL
| $1.3M | 0.01% |
31,124
+12,471
| +67% | +$579K |
|
867
iRhythm Holdings
IRTC
$4.06B
| $1.3M | 0.01% |
+19,584
| New | +$1.55M |
|
868
ITT
ITT
$18.4B
| $1.3M | 0.01% |
+14,160
| New | +$1.32M |
|
|
CCC
869
CCC Intelligent Solutions
CCC
$4.39B
| $1.29M | 0.01% |
129,998
-140,411
| -52% | -$1.42M |
|
870
Grand Canyon Education
LOPE
$3.89B
| $1.29M | 0.01% |
+14,359
| New | +$1.42M |
|
871
Warner Music
WMG
$14.7B
| $1.29M | 0.01% |
+35,862
| New | +$1.29M |
|
|
SGI
872
Somnigroup International
SGI
$13.5B
| $1.29M | 0.01% |
32,975
-38,533
| -54% | -$1.48M |
|
873
Molina Healthcare
MOH
$10.4B
| $1.28M | 0.01% |
+5,070
| New | +$1.27M |
|
874
Brady Corp
BRC
$4.41B
| $1.28M | 0.01% |
22,866
+10,140
| +80% | +$570K |
|
875
Allegion
ALLE
$13.6B
| $1.28M | 0.01% |
9,191
+7,232
| +369% | +$988K |
|
Similar funds
Michael Gelband's Q2 2021 Portfolio in Review
As of Q2 2021, Michael Gelband held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Michael Gelband deployed $1.88B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.
- Michael Gelband's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
- Michael Gelband added most to Microsoft in Q2 2021, an estimated $435M increase.
- Michael Gelband's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
- Michael Gelband fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
- Michael Gelband's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
- Michael Gelband opened 1,032 new positions and closed 820 in Q2 2021.
- Michael Gelband's portfolio value rose 32% quarter-over-quarter to $9.04B.
Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.